SHEL.UK

3,308

+0.3%↑

BP

572

+0.51%↑

REN

31.14

+0.71%↑

SDR

578.5

0%↓

PSON

1,074.5

-0.19%↓

SHEL.UK

3,308

+0.3%↑

BP

572

+0.51%↑

REN

31.14

+0.71%↑

SDR

578.5

0%↓

PSON

1,074.5

-0.19%↓

SHEL.UK

3,308

+0.3%↑

BP

572

+0.51%↑

REN

31.14

+0.71%↑

SDR

578.5

0%↓

PSON

1,074.5

-0.19%↓

SHEL.UK

3,308

+0.3%↑

BP

572

+0.51%↑

REN

31.14

+0.71%↑

SDR

578.5

0%↓

PSON

1,074.5

-0.19%↓

SHEL.UK

3,308

+0.3%↑

BP

572

+0.51%↑

REN

31.14

+0.71%↑

SDR

578.5

0%↓

PSON

1,074.5

-0.19%↓

Search

Smith & Nephew PLC

Закрыт

1,157 -2.94

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1155

Макс.

1161

Ключевые показатели

By Trading Economics

Доход

47M

342M

Продажи

318M

3.3B

P/E

Средняя по отрасли

23.774

77.607

Прибыль на акцию

0.429

Дивидендная доходность

3.1

Рентабельность продаж

10.36

Сотрудники

16,988

EBITDA

162M

886M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+26.13% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

3.10%

3.49%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-391M

11B

Предыдущая цена открытия

1159.94

Предыдущая цена закрытия

1157

Smith & Nephew PLC График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 апр. 2026 г., 19:19 UTC

Приобретения, слияния, поглощения

Intertek Group Rejects EQT's Revised Offer

24 апр. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Scoring the Cook Era -- Barrons.com

24 апр. 2026 г., 20:51 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 20:50 UTC

Обсуждения рынка
Главные новостные события

Financial Services Roundup: Market Talk

24 апр. 2026 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

24 апр. 2026 г., 20:39 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 20:09 UTC

Отчет

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 апр. 2026 г., 19:48 UTC

Обсуждения рынка
Главные новостные события

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 апр. 2026 г., 19:25 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 19:25 UTC

Приобретения, слияния, поглощения

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 апр. 2026 г., 19:22 UTC

Отчет

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 апр. 2026 г., 19:06 UTC

Отчет

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 апр. 2026 г., 19:05 UTC

Обсуждения рынка

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 апр. 2026 г., 18:30 UTC

Приобретения, слияния, поглощения

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 апр. 2026 г., 18:28 UTC

Приобретения, слияния, поглощения

Intertek Rejects Revised EQT Offer

24 апр. 2026 г., 18:12 UTC

Обсуждения рынка

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 апр. 2026 г., 18:06 UTC

Обсуждения рынка

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 апр. 2026 г., 17:42 UTC

Отчет

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 апр. 2026 г., 17:28 UTC

Отчет

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

24 апр. 2026 г., 17:28 UTC

Обсуждения рынка

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

24 апр. 2026 г., 17:12 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

24 апр. 2026 г., 17:11 UTC

Обсуждения рынка

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

24 апр. 2026 г., 17:09 UTC

Обсуждения рынка
Отчет

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

24 апр. 2026 г., 17:09 UTC

Приобретения, слияния, поглощения

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 17:06 UTC

Отчет
Приобретения, слияния, поглощения

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

24 апр. 2026 г., 16:51 UTC

Отчет
Приобретения, слияния, поглощения

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

24 апр. 2026 г., 16:20 UTC

Обсуждения рынка
Отчет

Tech, Media & Telecom Roundup: Market Talk

24 апр. 2026 г., 16:20 UTC

Обсуждения рынка
Главные новостные события

Financial Services Roundup: Market Talk

24 апр. 2026 г., 16:20 UTC

Обсуждения рынка
Отчет

Auto & Transport Roundup: Market Talk

24 апр. 2026 г., 16:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC Прогноз

Целевая цена

By TipRanks

26.13% рост

Прогноз на 12 месяцев

Средняя 1,460.57 GBX  26.13%

Максимум 1,700 GBX

Минимум 1,300 GBX

Основано на мнении 7 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

7 ratings

4

Покупка

3

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat